Physician profile
Kimberlee Mudge
NPI 1366425316
$578.30
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2021: $16.65 · 2023: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $124.11 | 2023 | Enhertu |
| Organogenesis INC. | $86.20 | 2019-2023 | Puraply |
| Lsi Solutions INC | $57.79 | 2019 | |
| Smith+Nephew, INC. | $52.93 | 2021-2023 | Renasys Go V2 Home, Pico |
| Genentech USA, INC. | $41.30 | 2019 | |
| Braintree Laboratories, INC. | $36.03 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $34.19 | 2019 | |
| Merck Sharp & Dohme LLC | $30.70 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $26.78 | 2019 | |
| Biocomposites INC | $24.30 | 2023 | Stimulan |
| Angiodynamics, INC. | $22.06 | 2019 | |
| Cook Medical LLC | $14.49 | 2019 | |
| Zimmer Biomet Holdings, INC. | $14.13 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $13.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kimberlee Mudge listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.